假尿苷合成酶1通过mRNA假尿苷化增强致癌mRNA翻译促进肝细胞癌
研究探索假尿苷合成酶1(PUS1)在肝细胞癌(HCC)中的作用及机制。分析TCGA数据发现PUS1在HCC中显著上调且与肿瘤分级和不良预后正相关;敲低PUS1抑制细胞增殖和皮下移植瘤生长,过表达则促进;PUS1催化活性为HCC肿瘤发生所必需;机制上PUS1将假尿苷引入一组致癌基因mRNA,增强其翻译能力。
要点
- PUS1在HCC中显著上调,与肿瘤分级和不良预后正相关。
- 敲低PUS1抑制细胞增殖和肿瘤生长,过表达则促进。
- PUS1催化活性为HCC肿瘤发生所必需。
核心结论
- PUS1和假尿苷化在HCC发生发展中起关键作用。
- PUS1通过假尿苷化介导的mRNA翻译增强包括IRS1和c-MYC在内的一组致癌基因的蛋白水平。
研究设计与样本
- 分析TCGA数据集。
- 使用皮下移植瘤小鼠模型。
- 使用流体动力学尾静脉注射建立的HCC小鼠模型。
- 利用APOBEC1介导的靶标图谱分析PUS1的mRNA靶标。
主要发现
- TCGA数据显示PUS1在人类HCC标本中显著上调,与肿瘤分级和不良预后正相关。
- 敲低PUS1抑制细胞增殖和皮下移植瘤小鼠模型的肿瘤生长;过表达PUS1的细胞增殖和肿瘤生长增加。
- 过表达PUS1显著加速流体动力学尾静脉注射HCC小鼠模型的肿瘤形成,敲除PUS1则减少肿瘤形成。
- PUS1催化活性为HCC肿瘤发生所必需。
- PUS1将假尿苷掺入一组致癌基因的mRNA,赋予其更强的翻译能力。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Pseudouridine is a prevalent RNA modification and is highly present in the serum and urine of patients with HCC. However, the role of pseudouridylation and its modifiers in HCC remains unknown. We investigated the function and underlying mechanism of pseudouridine synthase 1 (PUS1) in HCC. APPROACH AND RESULTS: By analyzing the TCGA data set, PUS1 was found to be significantly upregulated in human HCC specimens and positively correlated with tumor grade and poor prognosis of HCC. Knockdown of PUS1 inhibited cell proliferation and the growth of tumors in a subcutaneous xenograft mouse model. Accordingly, increased cell proliferation and tumor growth were observed in PUS1-overexpressing cells. Furthermore, overexpression of PUS1 significantly accelerates tumor formation in a mouse HCC model established by hydrodynamic tail vein injection, while knockout of PUS1 decreases it. Additionally, PUS1 catalytic activity is required for HCC tumorigenesis. Mechanistically, we profiled the mRNA targets of PUS1 by utilizing surveying targets by apolipoprotein B mRNA-editing enzyme 1 (APOBEC1)-mediated profiling and found that PUS1 incorporated pseudouridine into mRNAs of a set of oncogenes, thereby endowing them with greater translation capacity. CONCLUSIONS: Our study highlights the critical role of PUS1 and pseudouridylation in HCC development, and provides new insight that PUS1 enhances the protein levels of a set of oncogenes, including insulin receptor substrate 1 (IRS1) and c-MYC, by means of pseudouridylation-mediated mRNA translation.
引用
- Hu YX, Diao LT, Hou YR, et al. Pseudouridine synthase 1 promotes hepatocellular carcinoma through mRNA pseudouridylation to enhance the translation of oncogenic mRNAs. Hepatology. 2023. PMID: 38015993. doi:10.1097/HEP.0000000000000702
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。